com

Question 1

Neisseria meningitidis

Answer 1

1. each dose of the multivalent vaccine provides A, C, Y and W-135
2. capsular polysaccharides
3. capsular polysaccharides

Question 2

Streptococcus pneumoniae - each dose of the multivalent vaccine provides

Answer 2

23 types of capsular polysaccharide covering the majority of strains causing meningitis.

Question 3

Streptococcus pneumoniae Recommended for

Answer 3

children over 2 years of age.

Question 4

Haemophilus influenzae –

. Recommended for

Answer 4

children over 18 months of age

Question 5

Haemophilus influenzae –

each dose of

Answer 5

the monovalent vaccine provides the capsular polysaccride from serotype b.

Question 6

Meningococcal Vaccines

Answer 6

Menactra (MCV4-D)
Menveo (MCV4-CRM)
Polysaccharide vaccine (MSPV4)

Question 7

Polysaccharide vaccine (MSPV4)

Answer 7

Licensed in 1978, for use in those > 2 years of age, SC
Polysaccharide from A,C,Y,W-135
Requires reconstitution
*Meningococcal *Conjugate vaccine

Question 8

Menveo (MCV4-CRM)

Answer 8

Licensed 2010
Approved for use in those 2 months–55 years, IM
A,C,Y,W-135 conjugated to CRM197
Requires reconstitution
*Meningococcal *Conjugate vaccine

Question 9

Menactra (MCV4-D)

Answer 9

*Meningococcal *Conjugate vaccine
Licensed 2005
Approved for use in those 9 months–55 years, IM
A,C,Y,W-135 conjugated to diphtheria toxoid
Does not require reconstitution